Patent ID: 7939329
Filing Date: 2011-05-10
Classification: G01N

Abstract:
1. A method of preparing an individualized ischemic event risk assessment and individualized treatment for a subject, the method comprising: evaluating a first blood sample portion obtained from a subject to determine a first clot characteristic related quantitative indication of hemostasis of the first blood sample portion; determining a parameter indicative of the risk of the subject having an ischemic event based upon the first clot characteristic related quantitative indication of hemostasis and determining a treatment for the subject based upon the parameter; evaluating a second blood sample portion obtained from the subject post in vivo administration of a coagulation therapy to determine a second clot characteristic related quantitative indication of hemostasis of the second blood sample portion; and determining a post therapy parameter indicative of the risk of the subject having an ischemic event based upon the second clot characteristic related quantitative indication of hemostasis and determining an efficacy of the coagulation therapy for the subject based upon the parameters; wherein evaluating each of the first sample portion and the second sample portion comprises emulating venus flow for each of the first blood sample portion and the second blood sample portion.